Spike GP 77–85 (HLA-A*02:01)
LLLNCLWSV is a linear peptidic epitope (epitope ID37536) studied as part of Spike glycoprotein from Human coronavirus 229E and Spike glycoprotein from Severe acute respiratory syndrome-related coronavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay
Sequence: | LLLNCLWSV | |
Gene: | S | |
Delivery: | 3 weeks | |
C-Terminus: | OH | |
N-Terminus: | H | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Spike glycoprotein | |
Allele: | HLA-A*02:01 | |
Application : | Flow Cytometry Immunohistochemistry |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Product number:
EP11419_1